Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice

Mark Hatfield, PhD, Neel Shah, BPharm, PhD, Tatiana Lawrence, MD, Ahuva Hanau, BS, Alex Lonshteyn, PhD, Derek Weycker, PhD

Blood (2019) 134 (Supplement_1): 4668.

https://doi.org/10.1182/blood-2019-123999

Published: 2019

Journal Articles

Drug Sensitivity Screening on Multiple Myeloma for Precision Cancer Therapy

Deepak Balaji balaji Thimiri Govinda Raj, PhD MSc, Mariaserena Giliberto, Andrea Cremaschi, PhD MSc, Sigrid Strand Skånland, PhD, Alexandra Gade, Geir Erland Tjønnfjord, MD DMsc, Fredrik H. Schjesvold, MD PhD, Ludvig Andre Munthe, MD PhD, Kjetil Tasken

Blood (2018) 132 (Supplement 1): 4677.

https://doi.org/10.1182/blood-2018-99-110669

Published: 2018

Journal Articles

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

Fabio Efficace, Gianluca Gaidano, Francesco Lo-Coco

Blood (2017) 130 (7): 859–866.

https://doi.org/10.1182/blood-2017-03-737403

Published: 2017

Journal Articles

Venetoclax Resistant Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Cells Are Also Resistant to ABL Inhibitors, Which Can be Overcome By Targeting the PI3K/AKT/ mTOR Pathway

Jessica T Leonard, MD, Jeffrey W. Tyner, PhD, Joelle Rowley, Marc M. Loriaux, Brian J. Druker, Bill H. Chang, MD PhD

Blood (2016) 128 (22): 1583.

https://doi.org/10.1182/blood.V128.22.1583.1583

Published: 2016

Journal Articles

In Vitro Chemosensitivity of Leukaemic Stem and Progenitor Cells to Gemtuzumab Ozogamicin (Mylotarg) in AML.

Mays Jawad, PhD, Ullas Mony, MSC, Nigel H. Russell, MBChB, Monica Pallis, PhD

Blood (2007) 110 (11): 650.

https://doi.org/10.1182/blood.V110.11.650.650

Published: 2007

NARROW

Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice

Drug Sensitivity Screening on Multiple Myeloma for Precision Cancer Therapy

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

Venetoclax Resistant Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Cells Are Also Resistant to ABL Inhibitors, Which Can be Overcome By Targeting the PI3K/AKT/ mTOR Pathway

In Vitro Chemosensitivity of Leukaemic Stem and Progenitor Cells to Gemtuzumab Ozogamicin (Mylotarg) in AML.

Email alerts

ASH Publications

American Society of Hematology

Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice

Drug Sensitivity Screening on Multiple Myeloma for Precision Cancer Therapy

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

Venetoclax Resistant Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Cells Are Also Resistant to ABL Inhibitors, Which Can be Overcome By Targeting the PI3K/AKT/ mTOR Pathway

In Vitro Chemosensitivity of Leukaemic Stem and Progenitor Cells to Gemtuzumab Ozogamicin (Mylotarg) in AML.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only